BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20716265)

  • 1. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3.
    McCredie MR; Paul C; Sharples KJ; Baranyai J; Medley G; Skegg DC; Jones RW
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):363-70. PubMed ID: 20716265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
    McCredie MR; Sharples KJ; Paul C; Baranyai J; Medley G; Jones RW; Skegg DC
    Lancet Oncol; 2008 May; 9(5):425-34. PubMed ID: 18407790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for women without conventional treatment for stage 1A (microinvasive) carcinoma of the cervix.
    Paul C; Sharples KJ; Baranyai J; Jones RW; Skegg DC
    Aust N Z J Obstet Gynaecol; 2018 Jun; 58(3):321-329. PubMed ID: 29405269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in CIN3 diagnosis.
    Schiffman M; Rodríguez AC
    Lancet Oncol; 2008 May; 9(5):404-6. PubMed ID: 18452848
    [No Abstract]   [Full Text] [Related]  

  • 5. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
    Sykes PH; Simcock BJ; Innes CR; Harker D; Williman JA; Whitehead M; van der Griend RA; Lawton BA; Hibma M; Fitzgerald P; Dudley NM; Petrich S; Eva L; Bergzoll C; Kathuria J; McPherson G; Tristram A; Faherty J; Hardie D; Robertson A; Robertson V; Pather S; Wrede CD; Gastrell F; Fentiman G; John M; White E; Parker C; Sadler L
    Am J Obstet Gynecol; 2022 Feb; 226(2):222.e1-222.e13. PubMed ID: 34534506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.
    Strander B; Andersson-Ellström A; Milsom I; Sparén P
    BMJ; 2007 Nov; 335(7629):1077. PubMed ID: 17959735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy related cervical cytological changes and clinical management].
    Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
    Strander B; Hällgren J; Sparén P
    BMJ; 2014 Jan; 348():f7361. PubMed ID: 24423603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological follow-up of women older than 50 years with high-grade cervical smear treated by large loop excision.
    Das N; Sutton V; Bevan J; Brinkmann D; Woolas R
    J Low Genit Tract Dis; 2009 Jul; 13(3):165-8. PubMed ID: 19550214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
    Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
    BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.
    He Y; Zhao Q; Geng YN; Yang SL; Yin CH; Wu YM
    Medicine (Baltimore); 2017 Apr; 96(17):e6700. PubMed ID: 28445274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ?
    Denny LA; Soeters R; Dehaeck K; Bloch B
    Br J Obstet Gynaecol; 1995 Jul; 102(7):545-8. PubMed ID: 7647056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia.
    Petry KU; Böhmer G; Iftner T; Davies P; Brummer O; Kühnle H
    Am J Obstet Gynecol; 2002 Jan; 186(1):28-34. PubMed ID: 11810080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.